GGrantIndex
← Leaderboards

Adi F Gazdar

University Of Texas Sw Med Ctr/Dallas

Google Scholar ↗PubMed ↗ORCID ↗
$7,194,906
Attributed
$7,194,906
Total exposure
5
Grants
3
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $1M · FY2005–09
$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09

Funding mix

By agency

NIH$7,194,906 · 5

By mechanism

U01$4,524,081 · 1
P50$1,734,825 · 2
R24$936,000 · 1
P30$0 · 1

Top collaborators

No co-investigators on record.

Most similar at University Of Texas Sw Med Ctr/Dallas

Same institution · by research overlap

Others in their field

Top investigators on “Lung Neoplasms”

Research focus

Lung NeoplasmsHuman TissueGene ExpressionEarly DiagnosisBiomarkerNeoplasm /Cancer DiagnosisCell LineNeoplastic ProcessClinical ResearchTobacco AbusePreneoplastic StateCancer RiskBiomedical FacilityTissue Resource /RegistryDissectionTissue /Cell PreparationRespiratory EpitheliumBiopsyNeoplasm /Cancer GeneticsTumor Suppressor GenesHistopathologyHuman Genetic Material TagChromosome DeletionGenetic Markers

Grant awards (40)

Novel Reagents and New Biomarkers for Lung Cancer$307,500
U01 · FY2009 · CA · contact PI
Novel Reagents and New Biomarkers for Lung Cancer$419,268
U01 · FY2008 · CA · contact PI
Novel Reagents and New Biomarkers for Lung Cancer$408,750
U01 · FY2007 · CA · contact PI
Apoptosis and invasion genes in lung cancer$356,297
P50 · FY2007 · CA · contact PI
CORE--PATHOLOGY AND TISSUE RESOURCES$221,978
P50 · FY2007 · CA · contact PI
Novel Reagents and New Biomarkers for Lung Cancer$444,908
U01 · FY2006 · CA · contact PI
Apoptosis and invasion genes in lung cancer$356,297
P50 · FY2006 · CA · contact PI
CORE--PATHOLOGY AND TISSUE RESOURCES$221,978
P50 · FY2006 · CA · contact PI
Novel Reagents and New Biomarkers for Lung Cancer$577,457
U01 · FY2005 · CA
Novel Reagents and New Biomarkers for Lung Cancer$417,050
U01 · FY2004 · CA
MARKERS FOR RISK ASSESSMENT/EARLY DETECTION OF LUNG AND$482,456
U01 · FY2003 · CA
UNIQUE TISSUE AND TUMOR PROCESSING FACILITY$234,000
R24 · FY2003 · CA
MARKERS FOR RISK ASSESSMENT/EARLY DETECTION OF LUNG AND$471,032
U01 · FY2002 · CA
UNIQUE TISSUE AND TUMOR PROCESSING FACILITY$234,000
R24 · FY2002 · CA
MARKERS FOR RISK ASSESSMENT/EARLY DETECTION OF LUNG AND$85,332
U01 · FY2002 · CA
Pilot--Methylation profiles of tumor suppressor genes in skin cancers$0
P30 · FY2002 · AR
MARKERS FOR EARLY LUNG CANCER DETECTION$0
P50 · FY2002 · CA
MARKERS FOR EARLY LUNG CANCER DETECTION$0
P50 · FY2002 · CA
CORE--PATHOLOGY AND TISSUE RESOURCES$0
P50 · FY2002 · CA
CORE--PATHOLOGY AND TISSUE RESOURCES$0
P50 · FY2002 · CA
MARKERS FOR RISK ASSESSMENT/EARLY DETECTION OF LUNG AND$460,548
U01 · FY2001 · CA
UNIQUE TISSUE AND TUMOR PROCESSING FACILITY$234,000
R24 · FY2001 · CA
CORE--PATHOLOGY AND TISSUE RESOURCES$0
P50 · FY2001 · CA
CORE--PATHOLOGY AND TISSUE RESOURCES$0
P50 · FY2001 · CA
MARKERS FOR EARLY LUNG CANCER DETECTION$0
P50 · FY2001 · CA
MARKERS FOR EARLY LUNG CANCER DETECTION$0
P50 · FY2001 · CA
MARKERS FOR EARLY LUNG CANCER DETECTION$0
P50 · FY2001 · CA
CORE--PATHOLOGY AND TISSUE RESOURCES$0
P50 · FY2001 · CA
MARKERS FOR RISK ASSESSMENT/EARLY DETECTION OF LUNG AND$449,780
U01 · FY2000 · CA
MARKERS FOR EARLY LUNG CANCER DETECTION$356,297
P50 · FY2000 · CA
UNIQUE TISSUE AND TUMOR PROCESSING FACILITY$234,000
R24 · FY2000 · CA
CORE--PATHOLOGY AND TISSUE RESOURCES$221,978
P50 · FY2000 · CA
CORE--PATHOLOGY AND TISSUE RESOURCES$0
P50 · FY2000 · CA
CORE--PATHOLOGY AND TISSUE RESOURCES$0
P50 · FY2000 · CA
CORE--PATHOLOGY AND TISSUE RESOURCES$0
P50 · FY2000 · CA
CORE--PATHOLOGY AND TISSUE RESOURCES$0
P50 · FY2000 · CA
MARKERS FOR EARLY LUNG CANCER DETECTION$0
P50 · FY2000 · CA
MARKERS FOR EARLY LUNG CANCER DETECTION$0
P50 · FY2000 · CA
MARKERS FOR EARLY LUNG CANCER DETECTION$0
P50 · FY2000 · CA
MARKERS FOR EARLY LUNG CANCER DETECTION$0
P50 · FY2000 · CA